Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
CN Stock MarketDetailed Quotes
Zhejiang Orient Gene Biotech (688298)
- 22.33
- +0.15+0.68%
Market Closed Apr 30 15:00 CST
4.50BMarket Cap-8.16P/E (TTM)
22.35High22.13Low844.34KlotVolume22.15Open22.18Prev Close18.81MTurnover0.42%Turnover RatioLossP/E (Static)201.60MShares30.6552wk High0.76P/B4.50BFloat Cap21.5252wk Low26.62Limit Up201.60MShs Float239.67Historical High17.74Limit Down0.99%Range %21.14Historical Low--Dividend TTM22.28Avg Price381.61KlotAsk--Div Yield TTM1Lot Size433.08KlotBid
Zhejiang Orient Gene Biotech (688298) Income Statement
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 33.50%256.26M | 14.43%947.38M | 2.16%671.81M | -3.62%403.08M | 4.94%191.95M | 0.95%827.92M | 0.83%657.61M | -16.61%418.24M | -51.36%182.92M | -90.65%820.16M |
| Operating revenue | 33.50%256.26M | 14.43%947.38M | 2.16%671.81M | -3.62%403.08M | 4.94%191.95M | 0.95%827.92M | 0.83%657.61M | -16.61%418.24M | -51.36%182.92M | -90.65%820.16M |
| Total operating cost | 12.18%346.31M | 7.30%1.34B | -11.53%898.68M | -6.74%582.11M | 7.73%308.69M | 24.76%1.25B | 41.33%1.02B | 36.41%624.19M | -32.46%286.55M | -80.22%1B |
| Operating cost | 4.96%146.34M | -0.75%560.9M | -8.71%392.09M | -6.63%251.45M | 12.68%139.43M | 20.91%565.13M | 4.75%429.48M | -16.80%269.3M | -51.08%123.75M | -89.17%467.4M |
| Operating tax surcharges | 63.77%4.78M | 30.68%19.87M | 106.25%10.57M | 142.93%7.5M | 148.62%2.92M | 0.93%15.21M | -9.18%5.13M | -13.10%3.09M | -59.81%1.17M | -83.17%15.07M |
| Operating expense | -2.72%42.94M | 1.11%190.99M | 15.75%133.86M | 22.26%88.64M | 27.10%44.14M | 16.46%188.89M | -1.22%115.65M | -4.94%72.5M | -13.63%34.73M | -66.57%162.19M |
| Administration expense | 3.13%92.7M | -1.42%402.31M | -10.05%271.24M | -11.61%180.87M | -0.15%89.89M | 9.60%408.12M | 20.62%301.54M | 29.73%204.64M | 16.59%90.02M | 37.56%372.36M |
| Financial expense | 166.36%17.53M | 70.97%-63.1M | -58.18%-72.64M | 16.21%-60.03M | 24.72%-26.42M | 21.14%-217.34M | 81.79%-45.92M | 68.49%-71.64M | -3,645.95%-35.09M | 54.32%-275.58M |
| -Interest expense (Financial expense) | -34.19%2.52M | -48.52%9.91M | -47.73%7.49M | -46.91%5.45M | 9.13%3.82M | 6.23%19.25M | 22.22%14.33M | 69.45%10.26M | 22.55%3.5M | 160.09%18.12M |
| -Interest Income (Financial expense) | -95.70%-32.8M | 58.37%-80.35M | 15.72%-70.57M | 33.70%-47.5M | 61.07%-16.76M | 7.06%-193M | 47.10%-83.74M | 29.15%-71.65M | -0.77%-43.05M | -77.73%-207.67M |
| Research and development | -28.47%42.01M | -20.54%230.81M | -22.07%163.55M | -22.30%113.68M | -18.40%58.73M | 11.36%290.49M | 11.56%209.88M | 18.23%146.3M | 38.65%71.96M | -49.01%260.86M |
| Credit Impairment Loss | -10.69%-4M | 72.81%-7.92M | -1,594.57%-6.27M | 119.83%1.29M | 22.85%-3.62M | -5.80%-29.13M | -1.44%419.63K | -2,780.04%-6.48M | -317.99%-4.69M | -573.14%-27.53M |
| Asset Impairment Loss | -160.19%-11.64M | -13.47%-199.37M | 1.01%-16.47M | -54.29%-13.92M | -37.64%-4.47M | 25.71%-175.7M | -3.54%-16.64M | 0.40%-9.02M | -108.64%-3.25M | 80.45%-236.51M |
| Other net revenue | ||||||||||
| Fair value change income | 295.21%3.04M | -114.98%-1.6M | -67.10%4.99M | -67.71%4.99M | -105.53%-1.56M | 218.52%10.65M | 1,730.91%15.16M | 1,763.22%15.46M | 3,127.97%28.15M | -641.47%-8.99M |
| Invest income | 188.63%7.1M | -70.84%8.68M | -92.20%5.52M | -91.80%3.48M | -83.90%2.46M | -29.13%29.78M | 132.89%70.76M | 98.60%42.5M | 43.84%15.28M | 597.51%42.01M |
| Net open hedge income | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Including: Investment income associates | -212.11%-472.43K | 7.47%-2.79M | 13.12%-2.08M | 17.38%-1.27M | 82.42%-151.37K | -101.49%-3.02M | -82.09%-2.39M | -235.75%-1.54M | -357.76%-861.11K | -178.28%-1.5M |
| Exchange income | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Asset deal income | 4,091.99%573.99K | 77.05%1.75M | 85.65%1.68M | 3,258.07%1.74M | -326.15%-14.38K | 651.87%987.65K | 655.10%904.17K | -158.53%-55.15K | -95.53%6.36K | -2,150.74%-178.97K |
| Other revenue | 369.98%2.16M | 48.06%10.61M | -35.73%3.21M | -33.60%2.5M | -32.44%459.87K | -75.70%7.17M | -40.98%5M | -31.23%3.76M | 53.58%680.7K | 20.13%29.5M |
| Operating profit | 24.84%-92.82M | -0.59%-582.24M | 17.11%-234.22M | -11.99%-178.95M | -83.07%-123.49M | -50.80%-578.83M | -535.82%-282.55M | -363.10%-159.78M | -4,565.92%-67.45M | -115.18%-383.83M |
| Add:Non operating Income | -91.18%2.83K | -91.27%776.76K | -95.65%299.8K | -92.37%279.79K | 97.72%32.04K | 111.18%8.89M | 61.70%6.89M | -12.92%3.67M | -97.56%16.2K | 1,219.25%4.21M |
| Less:Non operating expense | -89.69%12.4K | -86.82%2.03M | -60.24%806.31K | -516.91%-5.56M | -82.28%120.29K | -37.52%15.37M | -66.54%2.03M | -76.72%1.33M | -98.16%678.7K | -57.42%24.6M |
| Total profit | 24.88%-92.83M | 0.31%-583.49M | 15.47%-234.72M | -9.95%-173.11M | -81.41%-123.57M | -44.80%-585.31M | -500.53%-277.69M | -365.89%-157.45M | -80.90%-68.12M | -116.36%-404.23M |
| Less:Income tax cost | 309.50%5.88M | 184.37%13.91M | -2.58%-3.55M | -63.38%950.03K | -252.58%-2.8M | -217.42%-16.49M | -116.45%-3.46M | -87.80%2.59M | -79.01%1.84M | -96.24%14.04M |
| Net profit | 18.27%-98.7M | -5.02%-597.41M | 15.70%-231.17M | -8.76%-174.06M | -72.64%-120.77M | -35.99%-568.82M | -307.67%-274.23M | -521.76%-160.04M | -50.72%-69.96M | -119.94%-418.27M |
| Net profit from continuing operation | 18.27%-98.7M | -5.02%-597.41M | 15.70%-231.17M | -8.76%-174.06M | -72.64%-120.77M | -35.99%-568.82M | -307.67%-274.23M | -521.76%-160.04M | -50.72%-69.96M | -119.94%-418.27M |
| Net income from discontinuing operating | ---- | --0 | ---- | ---- | --0 | --0 | ---- | ---- | ---- | ---- |
| Less:Minority Profit | 8.64%-4.86M | 40.18%-23.81M | -53.60%-18.54M | -29.94%-10.96M | -104.38%-5.32M | -92.41%-39.8M | -335.88%-12.07M | -368.79%-8.44M | -166.42%-2.6M | -169.61%-20.69M |
| Net profit of parent company owners | 18.72%-93.84M | -8.43%-573.6M | 18.89%-212.63M | -7.58%-163.1M | -71.41%-115.45M | -33.06%-529.02M | -262.17%-262.16M | -535.56%-151.61M | -33.82%-67.35M | -119.23%-397.58M |
| Earning per share | ||||||||||
| Basic earning per share | 14.04%-0.49 | -10.78%-2.98 | 16.67%-1.1 | -10.53%-0.84 | -72.73%-0.57 | -36.55%-2.69 | -266.67%-1.32 | -547.06%-0.76 | -10.00%-0.33 | -116.00%-1.97 |
| Diluted earning per share | 14.04%-0.49 | -10.78%-2.98 | 16.67%-1.1 | -10.53%-0.84 | -72.73%-0.57 | -36.55%-2.69 | -266.67%-1.32 | -547.06%-0.76 | -10.00%-0.33 | -116.00%-1.97 |
| Other composite income | 36.64%-4.96M | -329.74%-28.78M | -24.13%-21.79M | -949.65%-21.83M | 6.37%-7.82M | -11.19%12.53M | -170.56%-17.55M | -91.12%2.57M | 37.01%-8.35M | -65.58%14.11M |
| Other composite income of parent company owners | 36.64%-4.96M | -329.74%-28.78M | -24.13%-21.79M | -949.65%-21.83M | 6.37%-7.82M | -11.19%12.53M | -170.56%-17.55M | -91.12%2.57M | 37.01%-8.35M | -65.58%14.11M |
| Total composite income | 19.39%-103.66M | -12.56%-626.19M | 13.30%-252.96M | -24.39%-195.89M | -64.21%-128.59M | -37.64%-556.29M | -588.35%-291.78M | -335.51%-157.48M | -31.23%-78.31M | -118.90%-404.16M |
| Total composite income of parent company owners | 19.85%-98.8M | -16.63%-602.38M | 16.19%-234.42M | -24.08%-184.92M | -62.83%-123.27M | -34.69%-516.49M | -488.79%-279.71M | -333.87%-149.04M | -19.05%-75.71M | -118.19%-383.48M |
| Total composite income of minority owners | 8.64%-4.86M | 40.18%-23.81M | -53.60%-18.54M | -29.94%-10.96M | -104.38%-5.32M | -92.41%-39.8M | -335.88%-12.07M | -368.79%-8.44M | -166.42%-2.6M | -169.61%-20.69M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | -- | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm